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Background: Robotic surgery is a new technique with the benefits of a three-dimensional view, the ability to use
multi-degree-of-freedom forceps, the elimination of physiological tremors, and a stable camera view. The aim of this
study was to evaluate the feasibility and short-term outcomes of robotic surgery for colorectal cancer as initial cases,
compared with conventional laparoscopic surgery.
Methods: From July 2010 to June 2013, ten patients with left-sided colon and rectal cancer underwent robotic
surgery, and 121 received conventional laparoscopic surgery. Both groups were balanced in terms of age, gender,
American Society of Anesthesiologists (ASA) score, body mass index (BMI), operative history, TNM staging, and tumor
location. Moreover, in order to improve objectivity and approximate a randomized controlled study, we used the
propensity score matching method. The matching was successful because the ROC analysis showed a well-balanced
curve (C= 0.535).
Results: Following propensity score matching, ten patients were included in the robotic surgery group and 20 patients
were included in the conventional laparoscopic surgery group. There were no significant differences in the short-term
clinicopathologic outcomes between the robotic surgery group and the conventional laparoscopic surgery
group. However, the operative time was significantly longer in the robotic surgery group than in the conventional
laparoscopic surgery group.
Conclusions: There were no significant differences between the robotic surgery group and the conventional
laparoscopic surgery group with respect to short-term clinicopathologic outcomes, with the exception of the
operative time. Our early experience indicates that robotic surgery is a promising tool, particularly in patients
with rectal cancer.
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Figure 1 Port placement for left colon cancer and rectal cancer.
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Laparoscopic surgery for colon cancer has become an
accepted standard treatment strategy in recent years not
only for early colon cancer but also for advanced disease,
with regard to oncological safety and feasibility [1-6].
However, there is little evidence in the literature regard-
ing the use of laparoscopic surgery in patients with rec-
tal cancer, and the application of the technique in this
setting remains controversial. The technical feasibility of
performing laparoscopic surgery in patients with rectal
cancer has been demonstrated by experienced laparo-
scopic surgeons; however, even experts report technical
difficulties due to the confined space in the pelvis and the
limitations of existing laparoscopic instruments, which
have a restricted range of movement compared with that
of the surgeon’s hands. Moreover, previous reports have
shown higher rates of conversion to open surgery, positive
circumferential margins, and increased anastomotic leak-
age in patients treated with laparoscopic surgery [4,7-10].
The technical difficulties encountered when performing
laparoscopic surgery for lower rectal cancer are primarily
due to the anatomy of the pelvis, which lacks a wide space
to use long, straight, and rigid laparoscopic instruments.
Robotic surgery is a new technique with the benefits
of a three-dimensional view, the ability to use multi-
degree-of-freedom forceps, the elimination of physio-
logical tremors, and a stable camera view. It has been
successfully applied in urologic surgery, and the anatomy
of the pelvis suggests that performing robotic surgery in
this setting is feasible, especially in patients undergoing
rectal cancer surgery. To date, several studies have dem-
onstrated the safety and feasibility, as well as acceptable
short-term outcomes, of robotic colorectal surgery [11-14].
However, evidence supporting the use of robotic surgery in
patients with colorectal cancer is limited, particularly with
respect to randomized controlled studies.
The aim of this study was to evaluate the feasibility of
robotic surgery compared with conventional laparo-
scopic surgery for colorectal cancer. We conducted a
matched case-control study using the propensity score
matching method to assess the short-term outcomes of
robotic surgery for colorectal cancer compared with
those of conventional laparoscopic surgery.
Methods
This study was performed with permission of the Ethics
Committee of the Hiroshima University.
We have maintained a prospective database of all op-
erations for colorectal cancer performed since April
1994. Although this study was a retrospective review of
data prospectively collected from our database, the pro-
pensity score matching method was employed. The in-
clusion criterion was the presence of left-sided colon
and rectal cancer. The robotic surgery group includedselected patients who completed treatment between July
2010 and June 2013 (N = 10). Patients who underwent
conventional laparoscopic surgery for left-sided colon
and rectal cancer between July 2010 and June 2013 were
selected for enrollment in the control group (N = 121).
This was a matched case-control study using the pro-
pensity score matching method to compare the outcomes
of robotic surgery and conventional laparoscopic surgery
for colorectal cancer. The patients were matched with re-
gard to age, gender, American Society of Anesthesiologists
(ASA) score, body mass index (BMI), history of prior ab-
dominal surgery, tumor location, clinical stage, and the
preoperative serum CEA level. No analyses of surgical pa-
rameters or outcomes were conducted until the groups
were definitively selected as the best comparison cohort
based on preoperative variables only. The perioperative re-
sults included the operative time, amount of estimated
blood loss, the need for open conversion or further
surgery, complications, flatus passage, the length of post-
operative hospital stay, and the number of retrieved
lymph nodes.Robotic surgical technique
After obtaining informed consent, each patient with left-
sided colon and rectal cancer was placed in the lithotomy
position. Both robotic surgery and conventional laparo-
scopic surgery were performed using a medial-to-lateral ap-
proach with left colic artery-preserving lymphadenectomy.
The robot used in this study was the da Vinci S Surgical
System (Intuitive Surgical, Sunnyvale, CA, USA). We
usually use three 8-mm trocars (Intuitive Surgical,
Sunnyvale, CA, USA) and three 12-mm trocars (Ethicon,
Inc., Cincinnati, OH, USA) (Figure 1). The trocar place-
ment doing the medial to lateral approach (Figure 2A;
lateral phase) and during the procedure in the pelvic
Figure 2 Port placement. (A) Port placement using the medial to
lateral approach (lateral phase). (B) Port placement in the pelvic
space (pelvic phase).
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We usually use monopolar scissors (R1) and cadiere
forceps (R3 or R4) for the right hand and bipolar scis-
sors (R2 or R5) for the left hand (Figure 3). Our pro-
cedure for lymph node dissection includes left colic
artery-preserving D3 to maintain a good blood supply
on the oral side of the colon.
The operative procedures for sigmoid colon, recto-
sigmoid, and upper rectal cancer were performed using
a 3-cm skin incision in the umbilicus, followed by
laparotomy. The specimen was then removed through
the incision, and reconstruction was performed in the
abdominal cavity under laparoscopy. On the other
hand, the specimen was removed from the anal side in
case of intersphincteric resection or abdominoperineal
resection.
Statistical analysis
All continuous variables are expressed as the median
(range) and were compared using the Mann-Whitney testFigure 3 Instruments of the da Vinci S-HD-assisted colorectal surgerybetween the robotic surgery and conventional laparoscopic
surgery groups. The chi-square test and Fisher’s exact test
were used to compare discrete variables.
Moreover, in order to improve objectivity and approxi-
mate a randomized controlled study, we used the pro-
pensity score matching method to balance the observed
covariates between the robotic surgery and conventional
laparoscopic surgery groups. The propensity score match-
ing method was employed to reduce treatment selection
bias and potential confounding biases due to differences
between the two treatment groups.
Propensity scores were calculated for each patient
using a multivariable logistic regression analysis based
on the following covariates: age, gender, American
Society of Anesthesiologists (ASA) score, body mass
index (BMI), operative history, tumor location, and
TNM staging. Discrimination was evaluated using the
c-statistics. This model yielded a c-statistics of 0.673
(95% CI, 0.515 to 0.830), indicating an appropriate
ability to differentiate between patients who underwent
robotic surgery and those who underwent conventional
laparoscopic surgery. For the prediction model, the cali-
bration was assessed according to the Hosmer-Lemeshow
goodness-of-fit test, which showed excellent calibration
(P = 0.863). One-to-two pair matching was performed
between the two treatment groups, pairing the patients
with the closest propensity scores (within 0.03 on a scale
of 0 to 1). This matching was successful, as the c-statistics
was well balanced (0.560, 95% CI, 0.340 to 0.780). Finally,
we compared the ten robotic surgery patients with 20
matched conventional laparoscopic surgery patients with
respect to short-term surgical outcomes.
All statistical analyses were performed using the SPSS
Statistics software program (version 22; SPSS Inc., Chicago,
IL, USA), with a P value of <0.05 being considered to indi-
cate statistical significance.device.
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Patient characteristics
A total of 131 patients (ten robotic surgeries and 121
conventional laparoscopic surgeries) were included in
this study. The patients in the robotic and conventional
laparoscopic groups were comparable in terms of age,
gender, American Society of Anesthesiologists (ASA)
score, body mass index (BMI), operative history, tumor
location, TNM staging, and the preoperative serum CEA
level. All patients were matched as closely as possible in
terms of their selection criteria and were well balanced
(data not shown). However, in order to improve object-
ivity and approximate a randomized controlled study, we
used the propensity score matching method. The data
for both groups are shown in Table 1. The median age
of the ten patients of the robotic surgery group was 64.5
years (range: 55 to 72), with that of the 20 patients of
the conventional laparoscopic surgery group was 64.0
years (range: 48 to 79) (P = 0.947). Six of the ten robotic
surgery patients were male, compared with 11 of the 20
laparoscopic patients (P = 1.000). The median BMI was
21.98 kg/m2 (range: 17.9 to 28.4) in the robotic surgery
group compared with 24.1 kg/m2 (range: 15.0 to 29.7) in
the conventional laparoscopic surgery group (P = 0.509).
Two (20%) of the patients on the robotic surgery group
and three (15%) of the patients in the conventional lap-
aroscopic surgery group had a previous history of sur-
gery (P = 1.000). There were no significant differencesTable 1 Patient demographic and clinical characteristics
after propensity score matching
Robotic Laparoscopic P value
(N = 10) (N = 20)
Age (years) 64.5(55 to 72) 64.0(48 to 79) 0.947
Sex (male/female) 6/4 11/9 1.000
















Preoperative serum CEA 3.0(1.1 to 31.3) 3.5(1.1 to 31.1) 0.758between the two groups in terms of the ASA score,
tumor location, surgical stage, or preoperative serum CEA
level (P = 0.666, 1.000, 0.931, and 0.758, respectively).Clinicopathological outcomes
The clinicopathological variables are compared in Table 2.
There were no surgical mortalities or patients requiring
reintervention within 30 days in either group. The median
operative length was significantly longer in the robotic
surgery group (median: 417 min, range: 295 to 629 min)
than in the conventional laparoscopic surgery group
(median: 290 min, range: 210 to 452 min) (P = 0.001).
There were also no significant differences in the amount
of estimated blood loss between the robotic surgery group
(median: 45.0 ml, range: 5 to 250 ml) and the conventional
laparoscopic surgery group (median: 55.0 ml, range: 15 to
300 ml) (P = 0.658). No patients required conversion to
open surgery in the robotic surgery group, while one pa-
tient (5.0%) in the conventional laparoscopic surgery
group was converted to open surgery (P = 1.000). No case
of reoperation due to complications was encountered in
either group. There were no significant differences in the
rate of postoperative complications (P = 0.584), and no op-
erative mortality was observed in either group. There were
also no significant differences regarding flatus passage
after surgery between the robotic surgery group (median:
1 day, range: 1 to 4 days) and the conventional laparo-
scopic surgery group (median: 1 day, range: 1 to 3 days)
(P = 0.644). In terms of the length of hospital stay, the
median stay of 9.0 days observed in the robotic surgery
group (range: 7 to 17 days) was not significantly shorter
than that of 11.0 days noted in the conventional laparo-
scopic surgery group (range: 7 to 39 days) (P = 0.243). The
median number of lymph nodes harvested was also not
significantly different between the robotic surgery group
(median: 14.0, range: 2 to 18) and the conventionalTable 2 Clinicopathological outcomes after propensity
score matching
Robotic Laparoscopic P value
(N = 10) (N = 20)
Mean operating time (min) 417(295 to 629) 290(210 to 452) 0.001
Estimated blood loss (g) 45(5 to 250) 55(15 to 300) 0.658
Further surgery 0 0
Postoperative complication 2 2 0.584
Anastomotic leakage 1
Ileus 1
Wound problem 1 1
Flatus (days) 1(1 to 4) 1(1 to 3) 0.644
Postoperative hospital stay 9(7 to 17) 10.5(7 to 39) 0.243
Retrieved LN 14.0(2 to 18) 13.0(5 to 30) 0.243
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(P = 0.243).
Discussion
The apparent advantages of robotic surgery include a three-
dimensional view, the ability to use 7-degree-of-freedom
forceps, the elimination of physiological tremors, and
stable camera control.
In the urological field, robotic surgery has been ac-
cepted and evaluated with respect to both safety and ef-
ficacy [15,16]. In the field of colorectal surgery, the first
robotic surgery was reported in 2002 [17]. Since then,
robotic surgery has been gradually introduced into the
setting of rectal surgery as a result of its superior move-
ment and camera control in the narrow pelvic space.
However, there is inadequate evidence in the literature
regarding the feasibility and safety of this technique.
Although we experienced only a small number of cases
(ten cases) of robotic surgery for colorectal cancer, we
compared the outcomes of conventional laparoscopic
surgery (121 cases) using the propensity score match-
ing method in order to approximate a randomized
controlled study. To the best of our knowledge, our
case-matched study is the first study to use the pro-
pensity score matching method to compare the out-
comes of robotic and laparoscopic surgery in patients
with colorectal cancer.
In this study, we compared various parameters be-
tween the robotic surgery group and the conventional
laparoscopic surgery group. In order to evaluate the in-
vasiveness of the procedures, we compared the operative
length, amount of estimated blood loss, timing of flatus
passage, and length of postoperative hospital stay. In our
series, there were no significant differences in the amount
of estimated blood loss, timing of flatus passage, or length
of postoperative hospital stay between the robotic surgery
group and the conventional laparoscopic surgery group.
In terms of the operative length, the median 417 min ob-
served in the robotic surgery group (range: 295 to 629
min) was significantly longer than the 290 min noted in
the conventional laparoscopic surgery group (range: 210
to 452 min; P = 0.001). A longer operative time is one dis-
advantage of robotic surgery, in addition to the high cost,
lack of tactile sensation, and narrow visual field, as com-
pared with conventional laparoscopic surgery. However,
we believe that the technique of robotic surgery will im-
prove with experience after a learning curve. Indeed, pre-
vious studies have reported comparable operative times
between robotic surgery and conventional laparoscopic
surgery for rectal cancer [18,19].
With regard to the pathological findings, including tumor
differentiation, tumor depth, node metastasis, lymphatic in-
vasion, and vascular invasion, there were no significant
differences between the groups (data not shown). Interms of the median number of harvested lymph nodes,
there were no significant differences between the robotic
surgery group (median: 14.0, range: 2 to 18) and the con-
ventional laparoscopic surgery group (median: 13.0, range:
5 to 30; P = 0.243), as shown in Table 2. No patients had a
positive distal resection margin or positive circumferential
resection margin in either group.
The zero rate of conversion of robotic surgery for
colorectal cancer observed in this study is excellent, al-
though there were no significant differences between the
robotic surgery group and the conventional laparoscopic
surgery group. The rate of conversion of conventional
laparoscopic surgery was 5.0%, which is low compared
to the findings of other reports. Our series of robotic
surgery for colorectal cancer (N = 10) included no case
of conversion, and only two cases of surgical complica-
tions due to ileus and wound healing issues were ob-
served (Table 2); there were no severe complications.
Moreover, the postoperative recovery results, including
the timing of flatus passage and the length of postopera-
tive hospital stay, were similar between the two groups.
Our results demonstrated the feasibility and safety of
performing robotic surgery for colorectal cancer with re-
spect to perioperative outcomes.
This study was limited by its small sample size in the
robotic surgery group. However, in order to improve ob-
jectivity and approximate a randomized controlled study,
we used the propensity score matching method. The
matching was successful, as the c-statistics revealed a
well-balanced curve (0.535), indicating reliable results
with respect to the finding that robotic surgery is equiva-
lent to conventional laparoscopic surgery in patients with
colorectal cancer regarding short-term outcomes, includ-
ing perioperative and pathological results.
Moreover, this study provides an initial comparison
between robotic surgery and conventional laparoscopic
surgery for colorectal cancer which offers a foundation
for larger randomized controlled studies.
Conclusions
Our early experience indicates that robotic surgery is a
feasible and safe procedure in patients with colorectal
cancer. Although there were no significant benefits re-
garding the perioperative and oncological results, robotic
surgery provides better outcomes, especially in patients
undergoing rectal surgery. However, before extending
the indications for this procedure, it is necessary to
evaluate the perioperative and long-term oncological
safety in large randomized controlled trials.
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